ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,601 | 79.07495 | 1 | female | 0 | 9 | 989 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | null | null | null | 10.5 | black | 20.398438 | 43 | 0.796997 | 0.72998 | 2 | 0 | 0 | no | null | null | no dnr | 9 | 97 | 21.699219 | 75 | 28 | 37.19531 | 240.8125 | 3.299805 | 0.599976 | 9 | 140 | 7.399414 | null | null | null | null | null | null | 2.741211 |
3,602 | 72.70398 | 1 | male | 0 | 77 | 833 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 0 | 108,508.375 | 77,681.375 | null | 27 | white | 34.09375 | 69 | 0.511963 | 0.394958 | 4 | 1 | 0 | no | null | null | no dnr | 77 | 81 | 14.798828 | 110 | 32 | 38 | 140 | 1.899902 | 0.299988 | 2.899902 | 128 | 7.25 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,603 | 44.90598 | 1 | male | 0 | 17 | 338 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | null | 0 | 38,080.625 | 25,337.0625 | null | 27 | black | 32.59375 | 49 | 0.747925 | 0.668945 | 1 | 0 | 0 | no | 0.9 | 0.78 | no dnr | 17 | 121 | 14.798828 | 116 | 35 | 36.79688 | 155 | null | 1 | 2.799805 | 139 | 7.489258 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,604 | 50.75198 | 1 | male | 0 | 40 | 86 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 61,610.688 | 42,038.8438 | null | 28.5 | black | 34.09375 | 51 | 0.709961 | 0.549927 | 1 | 0 | 0 | no | null | null | no dnr | 40 | 55 | 8.398438 | 138 | 40 | 39 | 330 | 2.799805 | 1.5 | 1.5 | 129 | 7.489258 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,605 | 83.33997 | 1 | male | 0 | 3 | 1,443 | CHF | COPD/CHF/Cirrhosis | 4 | 16 | under $11k | 0 | 1,314.449 | 1,066.7598 | null | 16 | black | 14.199219 | 17 | 0.837891 | 0.733887 | 1 | 0 | 0 | yes | 0.95 | 0.75 | no dnr | 3 | 93 | 5.799805 | 80 | 20 | 36.39844 | null | null | 0.899902 | 1.199951 | 141 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
3,606 | 56.27399 | 1 | female | 1 | 21 | 21 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 61 | 72,193.188 | 48,118.1875 | null | 43.333313 | black | 29.398438 | 40 | 0.575928 | 0.381958 | 1 | 0 | 0 | no | 0.2 | 0.15 | dnr after sadm | 19 | 110 | 10 | 148 | 8 | 36.29688 | 300 | null | 3.799805 | 1.799805 | 130 | 7.379883 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
3,607 | 72.56097 | 0 | male | 0 | 11 | 1,804 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 8,884.898 | 6,848.4844 | null | 15.5 | black | 19.199219 | 31 | 0.8479 | 0.750977 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 103 | 4.699219 | 82 | 24 | 37 | 223.3125 | 3.199707 | null | 2 | 136 | 7.389648 | null | null | null | 0 | 0 | SIP>=30 | 0 |
3,608 | 45.14398 | 0 | male | 0 | 113 | 1,803 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 7 | null | 44 | 116,927.5 | 88,552.1875 | null | 27.25 | black | 23.796875 | 29 | 0.712891 | 0.625977 | 6 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 113 | 135 | 24.699219 | 114 | 30 | 38.09375 | 188.5625 | null | null | 0.899902 | 147 | 7.479492 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,609 | 65.65399 | 1 | female | 0 | 5 | 225 | CHF | COPD/CHF/Cirrhosis | 3 | 10 | under $11k | 0 | null | null | null | 12 | white | 13.5 | 21 | 0.914917 | 0.855957 | 1 | 0 | 0 | no | 0.75 | 0.422 | no dnr | 5 | 69 | 5.299805 | 72 | 20 | 36.29688 | 328.5625 | 3.599609 | 0.599976 | 1.099854 | 141 | 7.369141 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
3,610 | 28.66299 | 1 | female | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 37 | 44,095.188 | 29,580.2344 | null | 49 | black | 32.695313 | 77 | 0.332947 | 0.217987 | 2 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 7 | 67 | 0.399963 | 144 | 32 | 38.89844 | 226 | 2.199707 | 2.399902 | 1.699951 | 143 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 2.28125 |
3,611 | 69.85596 | 0 | female | 0 | 62 | 1,801 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 0 | 111,948.75 | 76,592.375 | null | 24.5 | black | 37.09375 | 57 | 0.504883 | 0.387939 | 1 | 0 | 0 | no | 0.25 | 0.15 | no dnr | 62 | 61 | 1.399902 | 130 | 26 | 37.79688 | 144.28125 | null | 0.399963 | 1.599854 | 129 | 7.449219 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,612 | 64.56897 | 1 | female | 1 | 12 | 12 | MOSF w/Malig | ARF/MOSF | 1 | 11 | null | 44 | 65,322.344 | 43,567.9688 | null | 33 | white | 30.296875 | 42 | 0.223999 | 0.125977 | 10 | 0 | 0 | yes | 0.15 | 0.1 | dnr after sadm | 6 | 129 | 11.298828 | 118 | 37 | 37.79688 | 380 | null | 0.799927 | 3.799805 | 153 | 7.329102 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,613 | 69.39398 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | under $11k | 61 | null | null | null | 40 | white | 26.796875 | 43 | 0.407959 | 0.28894 | 7 | 0 | 0 | no | null | null | dnr after sadm | 3 | 125 | 17.199219 | 180 | 36 | 38.89844 | 420 | null | null | 0.5 | 133 | 7.519531 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
3,614 | 51.61398 | 0 | female | 0 | 8 | 1,799 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 6,321.5 | 4,776.6172 | null | 8 | white | 26.796875 | 26 | 0.728882 | 0.575928 | 1 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 8 | 80 | 5.099609 | 100 | 24 | 36.79688 | 523.75 | null | 20.097656 | 0.799927 | 133 | 7.619141 | null | null | null | 5 | 5 | adl>=4 (>=5 if sur) | 5 |
3,615 | 69.02899 | 1 | male | 0 | 18 | 210 | MOSF w/Malig | ARF/MOSF | 1 | 10 | null | 0 | 50,995.469 | 35,083.5312 | null | 21 | white | 36.59375 | 68 | 0.248993 | 0.145996 | 13 | 0 | 0 | yes | 0.7 | 0.4 | no dnr | 18 | 70 | 0.199982 | 104 | 42 | 36.09375 | 142.5 | 1.899902 | null | 1.199951 | 132 | 7.55957 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,616 | 77.99298 | 1 | female | 1 | 25 | 25 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 7 | under $11k | 0 | 97,410.875 | 63,252.7812 | null | 39 | white | 38.296875 | 57 | 0.311951 | 0.198975 | 10 | 0 | 0 | no | null | null | dnr after sadm | 16 | 59 | 24.097656 | 130 | 12 | 38.09375 | 70 | 2.5 | 0.899902 | 3.299805 | 132 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,617 | 28.465 | 0 | female | 0 | 59 | 1,800 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $25-$50k | 0 | 175,319.625 | 116,491.938 | null | 45.75 | white | 32.5 | 64 | 0.809937 | 0.746948 | 1 | 1 | 0 | no | 0.2 | 0.2 | no dnr | 59 | 111 | 30.199219 | 150 | 24 | 37.79688 | 112.71875 | 2.899902 | 0.299988 | 5.899414 | 142 | 7.40918 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,618 | 54.409 | 1 | female | 0 | 6 | 1,017 | Lung Cancer | Cancer | 1 | null | null | 0 | 5,722.949 | 4,023.6309 | null | 16 | black | 16 | 20 | 0.75 | 0.490967 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | no dnr | 6 | 117 | 8.099609 | 62 | 18 | 36.89844 | null | null | 0.5 | 1.5 | 136 | null | null | null | null | null | null | null | 2.001953 |
3,619 | 72.85095 | 0 | female | 0 | 10 | 1,798 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 8,237.742 | 5,929.5586 | null | 13 | white | 17.796875 | 15 | 0.852905 | 0.757935 | 1 | 0 | 0 | no | 0.99 | 0.95 | no dnr | 10 | 100 | 6.699219 | 100 | 22 | 36.59375 | 285.6875 | 3.399902 | 0.399963 | 0.699951 | 144 | 7.449219 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
3,620 | 62.439 | 1 | female | 0 | 7 | 411 | Lung Cancer | Cancer | 1 | null | null | 0 | 8,158.945 | 5,384.2227 | null | 6 | black | 16.5 | 20 | 0.7229 | 0.447998 | 1 | 0 | 0 | metastatic | 0.8 | 0.2 | no dnr | 7 | 76 | 8 | 100 | 24 | 36.29688 | 271.375 | null | 0.799927 | 1.099854 | 140 | 7.459961 | null | null | null | null | null | null | 2.696289 |
3,621 | 50.41498 | 1 | male | 1 | 11 | 11 | Lung Cancer | Cancer | 1 | 13 | $25-$50k | 0 | 7,345.949 | 5,915.4453 | null | 8.5 | white | 24.199219 | 18 | 0.582886 | 0.262939 | 1 | 0 | 0 | metastatic | 0.2 | 0.01 | dnr after sadm | 7 | 77 | 6.5 | 120 | 24 | 36 | null | 3.099609 | 0.599976 | 1 | 138 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,622 | 42.56497 | 1 | female | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 2 | 10 | under $11k | 0 | 20,683.688 | 13,962.1172 | null | 37 | white | 29.097656 | 50 | 0.540894 | 0.426941 | 1 | 0 | 0 | metastatic | 0.15 | 0.15 | dnr after sadm | 2 | 120 | 29.097656 | 160 | 31 | 38.69531 | 113.32812 | 3.699707 | null | 1.099854 | 137 | 7.399414 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
3,623 | 69.93799 | 1 | male | 1 | 10 | 10 | Coma | Coma | 1 | 8 | under $11k | 100 | 26,657.688 | 18,507.6094 | null | 33 | black | 33.796875 | 44 | 0.017998 | 0.007 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 69 | 19.597656 | 130 | 22 | 40 | 147.5 | null | 0.5 | 3.699707 | 146 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,624 | 56.452 | 1 | male | 0 | 9 | 402 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 5,301.496 | 4,523.5391 | null | 12.5 | black | 20.296875 | 42 | 0.880981 | 0.80188 | 1 | 1 | 0 | no | null | null | no dnr | 9 | 75 | 9.398438 | 72 | 20 | 36.29688 | 271.375 | 3.799805 | 0.599976 | 5.399414 | 133 | 7.379883 | null | null | null | null | null | null | 2.793457 |
3,625 | 65.08997 | 1 | male | 0 | 134 | 585 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 44 | 361,896 | 240,649.75 | null | 48.5 | white | 39.898438 | 76 | 0.119995 | 0.052994 | 29 | 0 | 0 | no | 0.75 | 0.422 | dnr after sadm | 3 | 120 | 29.199219 | 118 | 36 | 35.79688 | 156.65625 | 2.899902 | 4.5 | 5.399414 | 134 | 7.359375 | null | null | null | null | 6 | no(M2 and SIP pres) | 6 |
3,626 | 42.02899 | 1 | male | 0 | 6 | 186 | Lung Cancer | Cancer | 3 | 14 | $11-$25k | 0 | 5,846.648 | 3,857.8223 | null | 16 | white | 14.898438 | 5 | 0.791992 | 0.560913 | 1 | 0 | 0 | metastatic | 0.85 | 0.5 | no dnr | 6 | 80 | 6.699219 | 78 | 16 | 36 | null | null | 0.199982 | 0.799927 | 139 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
3,627 | 21.13599 | 0 | male | 0 | 14 | 1,796 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 31,238.188 | 21,454.6875 | null | 17.333328 | white | 24.699219 | 28 | 0.883911 | 0.841919 | 1 | 0 | 0 | yes | 0.2 | 0.2 | no dnr | 14 | 135 | 2.899902 | 62 | 32 | 37.79688 | 384 | null | 2.599609 | 0.599976 | 136 | 7.479492 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,628 | 70.88599 | 0 | male | 0 | 35 | 1,796 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 26 | 68,258 | 48,212.6875 | null | 26.5 | white | 28.898438 | 47 | 0.595947 | 0.487976 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 35 | 55 | 11.398438 | 56 | 10 | 35.5 | 134 | 1.199951 | 0.5 | 1.299805 | 142 | 7.449219 | null | null | null | null | 5 | SIP>=30 | 5 |
3,629 | 63.28799 | 1 | female | 1 | 22 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | null | 0 | 88,884 | 58,544.5312 | null | 42 | white | 39.796875 | 67 | 0.473999 | 0.35498 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 17 | 57 | 19 | 134 | 30 | 38.19531 | 88 | null | 0.899902 | 4.5 | 133 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,630 | 70.81494 | 1 | female | 1 | 17 | 17 | Coma | Coma | 1 | 2 | under $11k | 44 | 42,977.75 | 30,679.125 | null | 32 | black | 26.296875 | 36 | 0.365967 | 0.291992 | 1 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 15 | 55 | 19.097656 | 64 | 8 | 36.59375 | 383.3125 | null | null | 2.399902 | 150 | 7.429688 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,631 | 67.66895 | 1 | male | 1 | 10 | 10 | Coma | Coma | 0 | 4 | under $11k | 37 | 39,055.375 | 26,184.4531 | null | 50 | white | 45.296875 | 100 | 0.021 | 0.008999 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 3 | 40 | 27.597656 | 150 | 30 | 40.19531 | 228 | null | 3.099609 | 9.798828 | 131 | 7.30957 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,632 | 47.03897 | 0 | male | 0 | 5 | 1,794 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 7 | under $11k | 0 | 3,280.449 | 2,724.5938 | null | 15 | white | 21.699219 | 28 | 0.832886 | 0.727905 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 5 | 92 | 8 | 100 | 24 | 36.5 | null | 1.799805 | 2.599609 | 0.699951 | 130 | null | null | null | null | 1 | null | null | 1.1669 |
3,633 | 77.18799 | 0 | male | 0 | 15 | 1,794 | COPD | COPD/CHF/Cirrhosis | 3 | 2 | null | 0 | 25,724.891 | 17,758.4375 | null | 24.333328 | other | 21.597656 | 35 | 0.775879 | 0.642944 | 1 | 0 | 0 | no | null | null | no dnr | 15 | 70 | 7.699219 | 142 | 8 | 38.09375 | 194.28125 | 3.299805 | 1.099854 | 1.199951 | 144 | 7.399414 | null | null | null | null | null | null | 2.947266 |
3,634 | 49.23798 | 0 | female | 0 | 5 | 1,785 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 8 | $11-$25k | 0 | 5,958.297 | 4,430.75 | null | 11 | white | 23.898438 | 34 | 0.791992 | 0.665894 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 5 | 60 | 4 | 72 | 20 | 35.5 | 500 | 2.799805 | 8 | 0.899902 | 133 | 7.449219 | null | null | null | 4 | 0 | no(M2 and SIP pres) | 0 |
3,635 | 62.68597 | 1 | male | 0 | 6 | 1,178 | Colon Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 5,468.949 | 3,953.1797 | null | 9 | white | 20.699219 | 20 | 0.765991 | 0.516968 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 6 | 107 | 5.599609 | 120 | 24 | 35.59375 | null | null | 0.599976 | 1.099854 | 141 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,636 | 68.03296 | 0 | male | 0 | 7 | 1,785 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 11,001.445 | 7,942.6523 | null | 11.5 | black | 18.898438 | 27 | 0.861938 | 0.771973 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 7 | 127 | 16.898438 | 68 | 26 | 35.79688 | 284 | null | 0.399963 | 1.199951 | 141 | 7.419922 | null | null | null | null | null | null | 2.250488 |
3,637 | 89.76294 | 1 | male | 1 | 22 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 0 | under $11k | 0 | 63,745.625 | 44,125.3438 | null | 41 | black | 28.898438 | 62 | 0.601929 | 0.494995 | 1 | 0 | 0 | no | 0.4 | 0.4 | dnr after sadm | 19 | 62 | 7.699219 | 58 | 4 | 35.29688 | 438.0625 | 2.399902 | null | 4.099609 | 136 | 7.369141 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,638 | 54.30798 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 13 | $25-$50k | 0 | 22,134.484 | 15,105.8516 | null | 39 | white | 27.199219 | 45 | 0.764893 | 0.689941 | 4 | 1 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 3 | 68 | 18.5 | 122 | 8 | 38.09375 | 188 | 2.099609 | 2.199707 | 0.799927 | 160 | 7.509766 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,639 | 48.586 | 0 | male | 0 | 45 | 1,784 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 6 | $11-$25k | 0 | 132,172.5 | 88,508.3125 | null | 37.75 | white | 28 | 30 | 0.805908 | 0.740967 | 1 | 0 | 0 | no | 0.4 | 0.3 | no dnr | 45 | 103 | 23.097656 | 132 | 28 | 39.39844 | 192.5 | null | 2.699707 | 1.199951 | 149 | 7.439453 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,640 | 64.28198 | 1 | male | 0 | 11 | 809 | CHF | COPD/CHF/Cirrhosis | 5 | 8 | $25-$50k | 0 | 6,832.246 | 5,436.1875 | null | 3.5 | white | 13.699219 | 27 | 0.915894 | 0.858887 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 11 | 97 | 6 | 76 | 28 | 36.29688 | 495.1875 | 4.399414 | 0.699951 | 2 | 139 | 7.429688 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,641 | 65.40997 | 1 | male | 0 | 5 | 67 | Lung Cancer | Cancer | 1 | 6 | null | 0 | 5,862.547 | 4,109.2969 | null | 11 | white | 14.5 | 9 | 0.753906 | 0.496948 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 5 | 119 | 5.099609 | 72 | 20 | 36.89844 | null | 3.399902 | 0.599976 | 0.899902 | 141 | null | null | null | null | 0 | null | null | 0.4948 |
3,642 | 68.159 | 1 | male | 1 | 8 | 8 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 4,788.25 | 3,870.5644 | null | 8.5 | white | 19.699219 | 30 | 0.85498 | 0.761963 | 1 | 0 | 0 | no | null | null | no dnr | 8 | 72 | 7.099609 | 84 | 24 | 35.89844 | null | null | null | 1.799805 | 133 | null | null | null | null | 2 | 1 | <2 mo. follow-up | 1 |
3,643 | 76.28198 | 1 | male | 0 | 8 | 24 | Lung Cancer | Cancer | 1 | null | null | 0 | 3,523.699 | 3,085.0391 | null | 3.5 | black | 17.597656 | 22 | 0.666992 | 0.366943 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 8 | 107 | 7.599609 | 68 | 16 | 35.19531 | null | null | null | 1 | 137 | null | null | null | null | null | null | <2 mo. follow-up | 3.051758 |
3,644 | 24.54999 | 1 | male | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 37 | 39,816.438 | 25,422.2656 | null | 43 | white | 31.097656 | 71 | 0.326965 | 0.211975 | 7 | 0 | 0 | yes | 0 | 0 | no dnr | 6 | 130 | 0.099991 | 150 | 55 | 37.89844 | 381 | 2.699707 | 0.5 | 1.099854 | 137 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 2.190918 |
3,645 | 68.40198 | 0 | female | 0 | 36 | 1,778 | CHF | COPD/CHF/Cirrhosis | 0 | 12 | under $11k | 0 | 85,186.938 | 52,831.0312 | null | 15.25 | white | 14.599609 | 13 | 0.901978 | 0.834961 | 1 | 0 | 0 | no | null | null | no dnr | 36 | 93 | 6.599609 | 80 | 20 | 36.39844 | null | null | 0.599976 | 1.099854 | 134 | null | null | null | null | 0 | 0 | null | 0 |
3,646 | 65.45898 | 1 | male | 0 | 8 | 33 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 8,641.648 | 6,417.7227 | null | 9.5 | white | 32.695313 | 59 | 0.460999 | 0.258972 | 1 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 8 | 73 | 8.099609 | 100 | 24 | 38.5 | null | 2.199707 | 10.298828 | 3.199707 | 126 | null | null | null | null | 4 | null | <2 mo. follow-up | 3.183199 |
3,647 | 67.10699 | 1 | female | 0 | 16 | 87 | Lung Cancer | Cancer | 1 | 9 | null | 9 | 16,886.344 | 12,085.1406 | null | 13 | white | 24.199219 | 26 | 0.487976 | 0.168976 | 1 | 0 | 0 | metastatic | 0.7 | 0.2 | dnr after sadm | 5 | 103 | 6.5 | 92 | 24 | 38.09375 | 137.5 | null | null | 0.599976 | 129 | 7.539062 | null | null | null | 5 | 1 | adl>=4 (>=5 if sur) | 1 |
3,648 | 56.08798 | 0 | male | 0 | 7 | 1,777 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 9 | $25-$50k | 0 | 3,525.949 | 3,032.9102 | null | 4.5 | white | 17.296875 | 17 | 0.845947 | 0.745972 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 7 | 83 | 3.199707 | 80 | 20 | 36.5 | null | 3 | 3.5 | 0.899902 | 134 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
3,649 | 32.73898 | 0 | male | 0 | 45 | 1,777 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | >$50k | 61 | 164,466.375 | 108,297.125 | null | 45.75 | white | 39.898438 | 50 | 0.31897 | 0.204987 | 3 | 0 | 0 | no | 0.25 | 0.25 | no dnr | 45 | 49 | 15.798828 | 148 | 15 | 39.29688 | 113.32812 | null | 3.799805 | 1.199951 | 132 | 7.459961 | null | null | null | null | 1 | null | 1 |
3,650 | 69.09796 | 1 | male | 1 | 16 | 16 | COPD | COPD/CHF/Cirrhosis | 3 | 11 | $11-$25k | 0 | 109,626.688 | 73,472.5 | null | 52.333313 | white | 46.695313 | 63 | 0.115997 | 0.022999 | 46 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 16 | 43 | 25.5 | 175 | 23 | 38.39844 | 160.84375 | 2.899902 | null | 1.199951 | 141 | 7.399414 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
3,651 | 65.27594 | 1 | female | 0 | 7 | 852 | Colon Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 6,469.598 | 4,429.7188 | null | 8.5 | white | 18.097656 | 13 | 0.800903 | 0.577881 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 7 | 100 | 6.099609 | 76 | 16 | 36 | null | 3.299805 | 0.399963 | 0.699951 | 142 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
3,652 | 67.77295 | 1 | male | 0 | 5 | 541 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 3,056.35 | 2,487.2656 | null | 7 | white | 20.097656 | 16 | 0.849976 | 0.753906 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 5 | 73 | 18.5 | 100 | 16 | 35.69531 | 340 | null | null | 1.099854 | 139 | 7.329102 | null | null | null | 3 | 0 | no(M2 and SIP pres) | 0 |
3,653 | 77.80194 | 1 | male | 0 | 5 | 16 | Lung Cancer | Cancer | 1 | 9 | under $11k | 0 | 2,793.549 | 2,199.8731 | null | 4 | white | 42.898438 | 28 | 0.040993 | 0 | 1 | 0 | 0 | metastatic | 0.25 | 0.05 | dnr after sadm | 1 | 110 | null | 84 | 20 | 36.09375 | null | 1 | null | null | 140 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,654 | 35.84399 | 0 | female | 0 | 48 | 1,775 | Coma | Coma | 0 | 17 | >$50k | 44 | 82,952.688 | 57,020.7188 | null | 23.75 | white | 19.5 | 16 | 0.807983 | 0.769897 | 1 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 48 | 75 | 18.398438 | 130 | 7 | 38 | 396 | null | 0.5 | 0.899902 | 137 | 7.479492 | null | null | null | null | 0 | SIP>=30 | 0 |
3,655 | 77.93799 | 1 | male | 1 | 9 | 9 | CHF | COPD/CHF/Cirrhosis | 5 | 11 | $25-$50k | 0 | 6,770.699 | 5,212.8438 | null | 11.5 | white | 27.699219 | 51 | 0.690918 | 0.525879 | 1 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 6 | 73 | 4.799805 | 156 | 28 | 35.89844 | null | 3.299805 | 1.599854 | 1.799805 | 145 | null | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,656 | 56.51199 | 1 | male | 0 | 13 | 19 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 11,222.547 | 8,539.25 | null | 10.5 | white | 28.5 | 29 | 0.62793 | 0.314941 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 13 | 89 | 8.798828 | 98 | 20 | 35.19531 | null | 3.199707 | 0.599976 | 3.199707 | 138 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,657 | 66.91595 | 1 | male | 0 | 5 | 388 | Lung Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 5,290.047 | 3,335.4199 | null | 15 | white | 9.898438 | 11 | 0.820923 | 0.613892 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 5 | 80 | 7.799805 | 76 | 20 | 36.69531 | null | 3.799805 | 0.299988 | 1.199951 | 143 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,658 | 58.94299 | 1 | female | 0 | 6 | 215 | CHF | COPD/CHF/Cirrhosis | 0 | 10 | under $11k | 0 | 6,483.449 | 5,730.9727 | null | 16 | white | 15.099609 | 14 | 0.915894 | 0.858887 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 6 | 65 | 9.898438 | 80 | 20 | 36.29688 | 323.75 | null | null | 1.199951 | 140 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,659 | 68.16394 | 1 | male | 1 | 3 | 3 | Lung Cancer | Cancer | 1 | null | null | 0 | 6,288.598 | 4,459.4961 | null | 20 | black | 32.898438 | 36 | 0.27594 | 0.040993 | 1 | 0 | 0 | metastatic | 0.3 | 0.1 | no dnr | 3 | 157 | 4.299805 | 20 | 48 | 35.79688 | 308.5625 | 2.899902 | 0.299988 | 0.799927 | 137 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.474609 |
3,660 | 63.41998 | 1 | female | 0 | 11 | 266 | CHF | COPD/CHF/Cirrhosis | 3 | 10 | null | 0 | 17,999.094 | 12,834.7578 | null | 19.5 | black | 21.898438 | 33 | 0.845947 | 0.746948 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 11 | 70 | 4.099609 | 44 | 22 | 36.09375 | 264 | null | 0.5 | 1.899902 | 137 | 7.549805 | null | null | null | 3 | 4 | no(M2 and SIP pres) | 4 |
3,661 | 81.31696 | 1 | male | 0 | 8 | 49 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | null | 0 | 4,875.238 | 3,819.4688 | null | 7 | black | 23.699219 | 34 | 0.75 | 0.605957 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 8 | 63 | 3.399902 | 66 | 16 | 36.09375 | null | 3.299805 | 0.199982 | 4.799805 | 147 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,662 | 69.17694 | 1 | male | 1 | 129 | 129 | COPD | COPD/CHF/Cirrhosis | 1 | 15 | >$50k | 0 | 398,248 | 272,052.25 | null | 46 | white | 32.398438 | 46 | 0.521973 | 0.32196 | 21 | 0 | 0 | no | 0.8 | 0.75 | dnr after sadm | 126 | 63 | 13.699219 | 110 | 32 | 36.59375 | 97 | null | 0.699951 | 1.299805 | 129 | 7.25 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,663 | 64.99695 | 0 | male | 0 | 7 | 1,770 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | $11-$25k | 0 | 7,358.797 | 5,338.8594 | null | 3.5 | white | 16 | 24 | 0.897949 | 0.829956 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 100 | 6.099609 | 78 | 20 | 36.39844 | null | null | null | 1.5 | 144 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,664 | 25.62099 | 1 | female | 0 | 30 | 45 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 434,315.75 | 289,424 | null | 34.25 | black | 39.398438 | 42 | 0.595947 | 0.487976 | 73 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 30 | 139 | 16 | 138 | 28 | 36.29688 | 91.65625 | 2.699707 | 7.799805 | 1 | 150 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,665 | 42.20398 | 0 | male | 0 | 10 | 1,768 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 16 | >$50k | 0 | 8,795.25 | 6,635.2422 | null | 11 | white | 28.097656 | 31 | 0.765991 | 0.628906 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 10 | 97 | 5.399414 | 72 | 28 | 38.59375 | null | 2.299805 | 5.899414 | 0.799927 | 120 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,666 | 52.375 | 1 | female | 0 | 15 | 185 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | under $11k | 0 | 20,454.188 | 15,171.6953 | null | 9.333328 | black | 16.796875 | 28 | 0.903931 | 0.868896 | 2 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 15 | 101 | 16.796875 | 80 | 24 | 38.09375 | 270 | 1.899902 | 2.699707 | 0.699951 | 138 | 7.40918 | null | null | null | 4 | 4 | no(M2 and SIP pres) | 4 |
3,667 | 57.86398 | 0 | male | 0 | 38 | 1,767 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 44 | 96,380.75 | 65,349.2812 | null | 32.25 | white | 28.097656 | 44 | 0.613892 | 0.508911 | 1 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 38 | 75 | 14.199219 | 62 | 42 | 36.39844 | 96.65625 | 1.199951 | 0.199982 | 0.799927 | 146 | 7.459961 | null | null | null | null | 1 | SIP>=30 | 1 |
3,668 | 55.086 | 1 | male | 0 | 8 | 231 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 5,840.5 | 4,412.2109 | null | 9.5 | white | 17.097656 | 10 | 0.727905 | 0.455994 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 8 | 80 | 2.299805 | 78 | 20 | 37.69531 | null | 3.199707 | 1 | 0.899902 | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,669 | 68.22699 | 1 | female | 0 | 32 | 661 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | under $11k | 0 | 112,743.062 | 74,369.5625 | null | 32 | white | 24.296875 | 41 | 0.741943 | 0.660889 | 7 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 32 | 134 | 10.199219 | 110 | 40 | 38.09375 | 183.3125 | 4.099609 | 0.799927 | 0.699951 | 145 | 7.479492 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,670 | 71.61694 | 1 | male | 0 | 52 | 440 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 16 | null | 0 | 153,677 | 106,389.438 | null | 22.5 | white | 25.597656 | 28 | 0.689941 | 0.5979 | 11 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 52 | 110 | 35.398438 | 130 | 7 | 36.39844 | 306.625 | null | null | 1.899902 | 139 | 7.349609 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.672852 |
3,671 | 54.44199 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 19,789.594 | 13,315.1406 | null | 13 | white | 40 | 65 | 0.259949 | 0.153992 | 8 | 0 | 0 | metastatic | 0.5 | 0.15 | dnr after sadm | 4 | 126 | 26.699219 | 176 | 44 | 38.09375 | 124 | null | 5.399414 | 0.699951 | 126 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 2.606934 |
3,672 | 68.59399 | 1 | female | 1 | 18 | 18 | CHF | COPD/CHF/Cirrhosis | 5 | 6 | null | 0 | 58,190.719 | 38,401.9062 | null | 35.666657 | black | 33.195313 | 38 | 0.625 | 0.439941 | 1 | 1 | 0 | no | 0.5 | 0.25 | dnr after sadm | 17 | 61 | 19.796875 | 108 | 27 | 35.59375 | 404 | null | null | 1.899902 | 124 | 7.5 | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
3,673 | 69.72998 | 1 | female | 0 | 5 | 1,034 | CHF | COPD/CHF/Cirrhosis | 3 | 6 | null | 0 | 3,366.648 | 2,877.0449 | null | 9 | white | 26.796875 | 24 | 0.750977 | 0.606934 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 5 | 69 | 5.699219 | 66 | 16 | 36.89844 | null | 2.699707 | 3.399902 | 0.799927 | 127 | null | null | null | null | 1 | 0 | SIP>=30 | 0 |
3,674 | 41.40698 | 1 | male | 0 | 44 | 209 | Coma | Coma | 0 | 16 | $25-$50k | 94 | 154,288.875 | 104,675.625 | null | 33.25 | black | 37.796875 | 67 | 0.102997 | 0.061996 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 44 | 65 | 15.898438 | 180 | 20 | 38.29688 | 133.3125 | 2.599609 | 5.599609 | 4.5 | 151 | 7.439453 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,675 | 63.87097 | 1 | female | 0 | 23 | 229 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $11-$25k | 0 | 48,938.531 | 34,675.1875 | null | 31.333328 | white | 38.5 | 78 | 0.507935 | 0.390991 | 1 | 0 | 0 | no | null | null | no dnr | 23 | 107 | 9.099609 | 162 | 28 | 35 | 309.5 | null | 13.199219 | 5.199219 | 138 | 7.40918 | null | null | null | null | 4 | no(M2 and SIP pres) | 4 |
3,676 | 46.72998 | 1 | male | 0 | 6 | 134 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 6,932.848 | 4,561.1914 | null | 10 | white | 15.5 | 11 | 0.863892 | 0.696899 | 1 | 0 | 0 | metastatic | 0.9 | 0.3 | no dnr | 6 | 107 | 7.5 | 96 | 20 | 37.29688 | null | null | 0.899902 | 1.099854 | 134 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,677 | 45.36899 | 1 | female | 0 | 9 | 60 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 6,296.898 | 4,840.4023 | null | 7.5 | white | 31.398438 | 22 | 0.397949 | 0.10199 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | no dnr | 9 | 70 | 10.599609 | 110 | 24 | 38.09375 | null | 2.199707 | 0.399963 | 1 | 136 | null | null | null | null | 3 | null | null | 2.511099 |
3,678 | 61.42398 | 1 | male | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 85,084.125 | 55,237.1562 | null | 39.666657 | white | 29.699219 | 43 | 0.695923 | 0.60498 | 3 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 6 | 61 | 10 | 126 | 32 | 38.79688 | 127.14062 | null | 1.599854 | 1.199951 | 131 | 7.359375 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,679 | 51.56699 | 1 | male | 1 | 4 | 4 | Coma | Coma | 1 | null | null | 94 | 22,312.328 | 15,496.0078 | null | 32 | white | 20.597656 | 21 | 0.286987 | 0.21698 | 9 | 0 | 0 | yes | null | null | dnr after sadm | 3 | 119 | 18.199219 | 132 | 12 | 39.29688 | 228 | 3 | 0.5 | 0.899902 | 138 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 2.317871 |
3,680 | 43.625 | 0 | female | 0 | 134 | 1,759 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $25-$50k | 0 | 401,867 | 269,131.25 | null | 42.5 | white | 26.097656 | 46 | 0.81897 | 0.758911 | 4 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 134 | 135 | 21.398438 | 130 | 26 | 37.59375 | 250 | null | 0.799927 | 9 | 143 | 7.449219 | null | null | null | 7 | 6 | adl>=4 (>=5 if sur) | 6 |
3,681 | 38.67999 | 1 | male | 1 | 8 | 8 | Coma | Coma | 2 | null | null | 100 | 71,634.188 | 46,963.0625 | null | 43 | white | 26.296875 | 50 | 0.312988 | 0.240997 | 8 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 8 | 136 | 25 | 108 | 8 | 36 | 330 | 1.899902 | null | 8 | 145 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 2.788574 |
3,682 | 66.84497 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 37 | 77,906.438 | 52,351.8438 | null | 41 | white | 38 | 62 | 0.118988 | 0.051994 | 25 | 1 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 5 | 105 | 24.699219 | 118 | 25 | 36.5 | 370 | 3 | 8.199219 | 2.799805 | 129 | 7.479492 | null | null | null | null | null | <2 mo. follow-up | 3.1875 |
3,683 | 58.56497 | 1 | male | 0 | 14 | 437 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 9 | under $11k | 0 | 18,640.047 | 13,730.0547 | null | 15.666664 | black | 27.296875 | 38 | 0.780884 | 0.708984 | 1 | 1 | 0 | no | 0.8 | 0.6 | no dnr | 14 | 78 | 24.898438 | 62 | 10 | 35.09375 | 217.125 | null | 1.399902 | 2.299805 | 134 | 7.389648 | null | null | null | 2 | null | null | 1.839 |
3,684 | 59.42798 | 0 | female | 0 | 88 | 1,757 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | $11-$25k | 0 | 284,272 | 195,666.125 | null | 32 | white | 24.199219 | 46 | 0.767944 | 0.692993 | 12 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 88 | 59 | 24.199219 | 122 | 40 | 38.59375 | 263.3125 | null | 1.399902 | 1.199951 | 145 | 7.349609 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
3,685 | 35.62198 | 0 | female | 0 | 67 | 1,757 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 100 | 200,353.75 | 132,550.25 | null | 46.25 | white | 29.097656 | 36 | 0.434998 | 0.314941 | 2 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 67 | 131 | 14.599609 | 108 | 12 | 39.19531 | 240 | null | 12.099609 | 0.899902 | 156 | 7.5 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
3,686 | 66.94299 | 1 | male | 0 | 24 | 59 | Lung Cancer | Cancer | 1 | null | null | 0 | 25,465.234 | 18,399.7969 | null | 15 | white | 20.296875 | 20 | 0.630981 | 0.31897 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 24 | 85 | 6.199219 | 116 | 24 | 35.69531 | null | null | 0.599976 | 1.199951 | 141 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,687 | 54.995 | 1 | male | 0 | 19 | 29 | CHF | COPD/CHF/Cirrhosis | 3 | 13 | $25-$50k | 0 | 22,609.641 | 16,044.7812 | null | 16.666656 | white | 23.5 | 36 | 0.852905 | 0.757935 | 1 | 0 | 0 | no | 0.7 | 0.2 | no dnr | 19 | 57 | 8.398438 | 65 | 16 | 35.29688 | null | null | null | 2 | 136 | null | null | null | null | 1 | 1 | <2 mo. follow-up | 1 |
3,688 | 60.51199 | 1 | female | 0 | 5 | 369 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 5,159.949 | 3,466.8379 | null | 11 | white | 18.898438 | 16 | 0.679932 | 0.383972 | 1 | 0 | 0 | metastatic | 1 | 0.8 | no dnr | 5 | 73 | 6.699219 | 110 | 16 | 36.89844 | null | null | 0.399963 | 0.599976 | 137 | null | null | null | null | 1 | 4 | no(M2 and SIP pres) | 4 |
3,689 | 57.84299 | 1 | female | 0 | 23 | 69 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | $25-$50k | 0 | 23,635.938 | 17,293.25 | null | 14.666664 | white | 26.398438 | 42 | 0.690918 | 0.524902 | 1 | 0 | 0 | no | null | null | no dnr | 23 | 77 | 12.5 | 80 | 18 | 36.19531 | 442.8125 | 2.599609 | 4.799805 | 4.099609 | 138 | 7.379883 | null | null | null | 2 | 0 | null | 0 |
3,690 | 41.42899 | 0 | male | 0 | 6 | 1,754 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | $11-$25k | 0 | 12,460.844 | 8,586.1641 | null | 8 | black | 20.597656 | 31 | 0.888916 | 0.849976 | 3 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 6 | 107 | 5.699219 | 108 | 22 | 37.69531 | 390.4375 | 3.399902 | 0.899902 | 12.398438 | 144 | 7.319336 | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
3,691 | 60.06 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | $25-$50k | 94 | 29,518.891 | 20,163.7969 | null | 44 | white | 43 | 74 | 0.011 | 0.002 | 8 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 4 | 61 | 31.5 | 126 | 30 | 38 | 137.75 | null | 19.5 | 4.599609 | 145 | 7.539062 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,692 | 73.19397 | 0 | male | 0 | 25 | 1,754 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 60,910.531 | 42,843.3125 | null | 18.75 | white | 24.199219 | 19 | 0.703979 | 0.613892 | 15 | 0 | 0 | no | 0.4 | 0.6 | no dnr | 25 | 80 | 13.699219 | 114 | 24 | 36 | 200 | null | null | 1.299805 | 136 | 7.459961 | null | null | null | null | 0 | SIP>=30 | 0 |
3,693 | 53.63998 | 1 | male | 1 | 8 | 8 | Lung Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 6,536.648 | 4,897.7344 | null | 11.5 | black | 31.398438 | 25 | 0.369995 | 0.084991 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | dnr after sadm | 8 | 83 | 10.798828 | 120 | 28 | 36.29688 | 280.9375 | 2.799805 | 0.699951 | 1 | 132 | 7.389648 | null | null | null | 3 | null | <2 mo. follow-up | 2.511099 |
3,694 | 74.68298 | 1 | female | 1 | 4 | 4 | Coma | Coma | 1 | 6 | under $11k | 55 | 11,897.195 | 8,313.8281 | null | 24 | black | 43.5 | 73 | 0 | 0 | 4 | 0 | 0 | metastatic | null | null | dnr after sadm | 2 | 131 | 18.199219 | 116 | 36 | 36 | 304 | null | 23.597656 | 2.099609 | 125 | 7.40918 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,695 | 73.862 | 0 | female | 0 | 14 | 1,750 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 37,997.719 | 25,638.7812 | null | 13.333328 | white | 19 | 19 | 0.80896 | 0.744995 | 6 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 14 | 123 | 9.798828 | 82 | 20 | 36.09375 | 176.65625 | null | null | 1 | 136 | 7.479492 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,696 | 72.12299 | 1 | male | 1 | 19 | 19 | Coma | Coma | 2 | 12 | under $11k | 0 | 70,576.5 | 47,851.1562 | null | 34.333313 | black | 24.199219 | 47 | 0.557983 | 0.48999 | 6 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 11 | 109 | 15.398438 | 82 | 75 | 39.09375 | 185 | 2.199707 | 0.699951 | 1.799805 | 145 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,697 | 58.52197 | 1 | male | 0 | 12 | 570 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $25-$50k | 0 | 21,888.344 | 14,721.5156 | null | 19.5 | white | 22.199219 | 30 | 0.856934 | 0.763916 | 1 | 1 | 0 | no | 0.7 | 0.5 | no dnr | 12 | 67 | 8.298828 | 118 | 26 | 36.19531 | null | null | 0.699951 | 1.399902 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,698 | 60.84598 | 1 | male | 0 | 18 | 644 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 16 | >$50k | 9 | 14,564.594 | 11,304.0547 | null | 7.333332 | white | 24.398438 | 32 | 0.67688 | 0.505981 | 1 | 1 | 0 | no | 0.99 | 0.97 | no dnr | 18 | 80 | 6.899414 | 106 | 24 | 39.09375 | 347.5625 | 1.899902 | 3.899902 | 0.799927 | 127 | 7.479492 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,699 | 59.85498 | 0 | male | 0 | 36 | 1,747 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 53,360.844 | 37,548.1562 | null | 17.5 | black | 25.699219 | 31 | 0.681885 | 0.587891 | 4 | 0 | 0 | no | 1 | 0.95 | no dnr | 36 | 101 | 20.296875 | 110 | 12 | 36.19531 | 322.1875 | 2.5 | null | 1.699951 | 146 | 7.429688 | null | null | null | null | null | no(M2 and SIP pres) | 3.025391 |
3,700 | 67.047 | 0 | female | 0 | 17 | 1,746 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $11-$25k | 0 | 21,429.297 | 15,346.4453 | null | 12.333328 | white | 25 | 9 | 0.758911 | 0.682983 | 3 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 17 | 118 | 11.699219 | 84 | 24 | 36.19531 | 215 | null | null | 0.5 | 127 | 7.459961 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.